Option 01
Senior Leadership
R & D
Commercial

Rajendra Kumar
Sahu
Chief Executive
Officer

Rajendra Kumar Sahu
Chief Executive Officer
Rajendra has over 26 years of rich experience working with large generic pharmaceutical companies like Dr Reddys, Glenmark, Ranbaxy and Sun Pharmaceutical handling a diverse set of roles spanning across projects, process engineering, technology transfer, production and business development.
Rajendra holds a Bachelor’s degree in Chemical Engineering from NIT, Rourkela and has done Strategic management program from IIM, Ahmedabad. He is working with Navin Fluorine since Apr’ 2020.

Jordi
Robinson
Chief Commercial
Officer
Jordi Robinson
Chief Commercial Officer
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.

Dr Raghavendar
Rao Morthala
Head,
R&D
Dr Raghavendar Rao Morthala
Head, R&D
Raghavendar Rao heads Process and Analytical R&D at Navin Molecular.
He has more than 20 years’ experience in Healthcare and Pharma Industries, specifically CDMO and API generics.
He is a synthetic organic chemist by training, with a PhD and Post-Doc from the University of Strathclyde, Glasgow, UK. His previous experience includes stints at Syngene International, Piramal Pharma Solutions, Sai Life Sciences, Dr Reddy’s and Government of Andhra Pradesh.

Ajay
Ohri
Head,
BD US

Ajay Ohri
Head, BD US
Ajay is a senior executive in the biopharma and chemical space with over 30 years’ of experience.
His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships.
t has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.

Dr Matthew
Stent
Head, BD Europe
& Key Accounts

Dr Matthew Stent
Head, BD Europe & Key Accounts
Matthew heads-up our European business development team and is responsible for strategic key accounts.
He joined Navin in 2015 and set up the project management function, building an international team to manage both pre-sales (RFP evaluation and quoting) and project delivery coordination (technical oversight and customer communication), and transitioned into his current commercial role in early 2023.
Matthew is a synthetic organic chemist by training: he has a DPhil from the University of Oxford, UK, completed a Post-Doc at the University of Texas, USA, and has more than 15 years’ experience in techno-commercial roles in customer facing positions.
Option 02
Senior Leadership

Rajendra Kumar Sahu
Chief Executive Officer
Rajendra has over 26 years of rich experience working with large generic pharmaceutical companies like Dr Reddys, Glenmark, Ranbaxy and Sun Pharmaceutical handling a diverse set of roles spanning across projects, process engineering, technology transfer, production and business development.
Rajendra holds a Bachelor’s degree in Chemical Engineering from NIT, Rourkela and has done Strategic management program from IIM, Ahmedabad. He is working with Navin Fluorine since Apr’ 2020.

Jordi Robinson
Chief Commercial Officer
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.
R & D

Dr Raghavendar Rao Morthala
Head, R&D
Raghavendar Rao heads Process and Analytical R&D at Navin Molecular. He has more than 20 years’ experience in Healthcare and Pharma Industries, specifically CDMO and API generics. He is a synthetic organic chemist by training, with a PhD and Post-Doc from the University of Strathclyde, Glasgow, UK. His previous experience includes stints at Syngene International, Piramal Pharma Solutions, Sai Life Sciences, Dr Reddy’s and Government of Andhra Pradesh.
Commercial

Ajay Ohri
Head, BD US
Ajay is a senior executive in the biopharma and chemical space with over 30 years’ of experience. His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships. It has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.

Dr Matthew Stent
Head, BD Europe & Key Accounts
Matthew heads-up our European business development team and is responsible for strategic key accounts. He joined Navin in 2015 and set up the project management function, building an international team to manage both pre-sales (RFP evaluation and quoting) and project delivery coordination (technical oversight and customer communication), and transitioned into his current commercial role in early 2023. Matthew is a synthetic organic chemist by training: he has a DPhil from the University of Oxford, UK, completed a Post-Doc at the University of Texas, USA, and has more than 15 years’ experience in techno-commercial roles in customer facing positions.
Option 03
Senior Leadership

Dr Matthew Stent
Head, BD Europe & Key Accounts
Matthew heads-up our European business development team and is responsible for strategic key accounts. He joined Navin in 2015 and set up the project management function, building an international team to manage both pre-sales (RFP evaluation and quoting) and project delivery coordination (technical oversight and customer communication), and transitioned into his current commercial role in early 2023. Matthew is a synthetic organic chemist by training: he has a DPhil from the University of Oxford, UK, completed a Post-Doc at the University of Texas, USA, and has more than 15 years’ experience in techno-commercial roles in customer facing positions.

Ajay Ohri
Head, BD US
Ajay is a senior executive in the biopharma and chemical space with over 30 years’ of experience. His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships. It has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.
Rajendra Kumar Sahu
Chief Executive Officer
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.
Jordi Robinson
Chief Commercial Officer
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.
Dr Raghavendar Rao Morthala
Head, R&D
Raghavendar Rao heads Process and Analytical R&D at Navin Molecular. He has more than 20 years’ experience in Healthcare and Pharma Industries, specifically CDMO and API generics. He is a synthetic organic chemist by training, with a PhD and Post-Doc from the University of Strathclyde, Glasgow, UK. His previous experience includes stints at Syngene International, Piramal Pharma Solutions, Sai Life Sciences, Dr Reddy’s and Government of Andhra Pradesh.
Ajay Ohri
Head, BD USAjay is a senior executive in the biopharma and chemical space with over 30 years’ of experience. His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships. It has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.